Sleep Apnea: Everything You Should Know About Diagnosis and Treatment

Sleep apnea is a serious sleep disorder in which breathing repeatedly stops and starts throughout the night. An estimated 30 million adults in the United States alone suffer from sleep apnea, yet the vast majority remain undiagnosed. Left untreated, sleep apnea raises the risk of hypertension, heart disease, stroke, type 2 diabetes, and cognitive decline. This guide covers everything you need to know about sleep apnea diagnosis and treatment, drawing on the latest evidence-based recommendations from organizations such as the American Academy of Sleep Medicine (AASM), the Mayo Clinic, Harvard Medical School, and the National Institutes of Health (NIH).

What Is Sleep Apnea? Types and Prevalence

Sleep apnea is characterized by repeated episodes of partial or complete upper airway obstruction during sleep, leading to oxygen desaturations, frequent arousals, and fragmented sleep. The condition is classified into three main types.

Obstructive sleep apnea (OSA) is the most common form, accounting for roughly 84% of cases. It occurs when the soft tissues of the throat and tongue relax excessively during sleep, collapsing the airway. Central sleep apnea (CSA) is less common and results from the brain failing to send proper signals to the muscles that control breathing. Complex or mixed sleep apnea involves both obstructive and central components.

According to the NIH, approximately 26% of adults aged 30 to 70 have some degree of sleep apnea, with men being two to three times more likely than women to develop the condition. The AASM reports that prevalence continues to rise in parallel with obesity rates. Despite these numbers, an estimated 80% of moderate-to-severe cases remain undiagnosed, making sleep apnea one of the most underdiagnosed public health issues today.

Recognizing the Signs: Symptoms of Sleep Apnea

Symptoms of sleep apnea can be subtle and are often dismissed as normal snoring or simple fatigue. Key indicators include loud and persistent snoring, episodes of gasping or choking during sleep (often reported by a bed partner), excessive daytime sleepiness, morning headaches, dry mouth upon waking, irritability, difficulty concentrating, and frequent nighttime urination.

The Epworth Sleepiness Scale is a validated questionnaire that clinicians use to quantify daytime sleepiness. A score of 10 or higher out of 24 suggests that a formal sleep evaluation may be warranted. Women may present with less typical symptoms such as insomnia, fatigue, and mood disturbances, which contributes to underdiagnosis in this population. The Mayo Clinic emphasizes that anyone experiencing these symptoms should discuss them with a healthcare provider.

Risk Factors and Causes

Several risk factors increase the likelihood of developing sleep apnea. Excess body weight is the strongest predictor—a BMI above 30 raises OSA risk by roughly tenfold. Neck circumference greater than 17 inches in men and 16 inches in women is also strongly correlated with airway collapsibility. Anatomical factors such as enlarged tonsils, a recessed chin (retrognathia), a large tongue (macroglossia), or a narrow palate can predispose individuals to obstruction.

Age is an independent risk factor; prevalence steadily increases through middle age and plateaus after age 65. Family history, smoking, alcohol consumption before bed, nasal congestion, and the use of sedatives or opioids all contribute to the condition. Endocrine disorders such as hypothyroidism, polycystic ovary syndrome (PCOS), and acromegaly are also linked to higher sleep apnea rates. The Harvard Medical School Division of Sleep Medicine notes that addressing modifiable risk factors can significantly reduce apnea severity.

Health Consequences of Untreated Sleep Apnea

Beyond poor sleep quality, untreated sleep apnea carries serious systemic health consequences. The repeated drops in blood oxygen levels trigger a cascade of physiological stress responses, including sympathetic nervous system activation, oxidative stress, and systemic inflammation. These mechanisms contribute to the development and worsening of hypertension, coronary artery disease, heart failure, atrial fibrillation, and stroke.

Metabolic effects include insulin resistance and a higher incidence of type 2 diabetes. Cognitive consequences involve impaired memory, reduced executive function, slower reaction times, and an elevated risk of dementia. Daytime sleepiness from untreated apnea significantly increases the risk of motor vehicle accidents—by as much as fivefold according to some studies. The National Heart, Lung, and Blood Institute (NHLBI) identifies sleep apnea as an independent risk factor for cardiovascular morbidity and mortality.

Importantly, effective treatment has been shown to reverse or mitigate many of these risks, making early diagnosis and intervention critical.

How Sleep Apnea Is Diagnosed: From Screening to Polysomnography

Diagnosis of sleep apnea follows a structured clinical pathway. It begins with a thorough medical history and physical examination. Your doctor will review your symptoms, ask about your sleep habits, examine your airway, and measure your neck circumference and BMI. The STOP-Bang questionnaire (Snoring, Tiredness, Observed apnea, high blood Pressure, BMI > 35, Age > 50, Neck circumference > 40 cm, male Gender) is a commonly used screening tool.

If the screening suggests moderate-to-high risk, the next step is objective sleep testing. The gold standard is attended in-laboratory polysomnography (PSG), which records brain waves (EEG), eye movements, heart rhythm, breathing effort, airflow, oxygen saturation, and leg movements throughout the night. This comprehensive study can distinguish between OSA, CSA, and other sleep disorders such as periodic limb movement disorder or narcolepsy.

Polysomnography yields the Apnea-Hypopnea Index (AHI), which quantifies severity: mild (5 to 14 events per hour), moderate (15 to 29), and severe (30 or more). In 2025, the AASM released updated guidelines emphasizing that the AHI should be interpreted alongside hypoxic burden and patient symptoms for more individualized care. You can read the full recommendations at the American Academy of Sleep Medicine website.

Home Sleep Apnea Testing vs. In-Lab Studies

Home sleep apnea testing (HSAT) has become increasingly popular as a more convenient and cost-effective alternative to in-lab PSG. HSAT devices typically record airflow, respiratory effort, oxygen saturation, and heart rate. They are most appropriate for patients with high pretest probability of moderate-to-severe OSA who do not have significant comorbidities such as heart failure, chronic obstructive pulmonary disease, or suspected central sleep apnea.

HSAT has limitations: it cannot detect sleep stages or arousals, may underestimate AHI, and has a higher rate of false negatives. If an HSAT result is negative or technically inadequate but clinical suspicion remains high, an in-lab PSG is recommended. The 2025 AASM and VA/DoD guidelines both support the use of HSAT for initial diagnosis in appropriately selected patients while maintaining that in-lab PSG remains the reference standard.

CPAP and Positive Airway Pressure Therapy

Continuous positive airway pressure (CPAP) is the first-line treatment for moderate-to-severe obstructive sleep apnea. The device delivers a steady stream of pressurized air through a mask, acting as a pneumatic splint to keep the airway open throughout the night. CPAP therapy dramatically reduces AHI, normalizes oxygen saturation, eliminates snoring, and improves subjective sleepiness. A 2025 AASM guideline specifically recommends initiating CPAP in hospitalized adults with newly diagnosed or previously untreated moderate-to-severe OSA.

Auto-titrating positive airway pressure (APAP or AutoPAP) adjusts pressure in real time based on detected flow limitations, which can improve comfort. Bi-level positive airway pressure (BiPAP) delivers higher pressure during inhalation and lower pressure during exhalation, often used for patients who cannot tolerate CPAP or have central sleep apnea or obesity hypoventilation syndrome.

Adherence to PAP therapy remains the most significant challenge. Studies suggest that 30 to 50% of patients stop using CPAP within the first year. Factors that improve adherence include proper mask fitting (nasal pillows, full-face, or nasal masks), heated humidification, ramping features, and behavioral support. The Harvard Health Publishing recommends working closely with a sleep specialist to troubleshoot mask leaks, pressure intolerance, and claustrophobia early in treatment.

Oral Appliances and Surgical Interventions

For patients with mild-to-moderate OSA who cannot tolerate or decline CPAP, oral appliance therapy (OAT) is an effective alternative. Mandibular advancement devices (MADs) reposition the lower jaw forward, increasing the size of the upper airway. Tongue-retaining devices hold the tongue in a forward position. These custom-fitted devices are typically fabricated by a dentist specializing in sleep medicine. The efficacy of OAT varies; AHI reduction averages 50 to 60%, and about two-thirds of patients achieve a treatment response.

Positional therapy is a simple strategy for patients whose apnea occurs predominantly while sleeping on their back. Wearable devices and specialized pillows that encourage side-sleeping can reduce AHI in this subgroup. Positional therapy is rarely sufficient as a standalone treatment for moderate-to-severe OSA but may complement other therapies.

Surgical options are reserved for patients with identifiable anatomical obstructions who have failed or cannot tolerate conservative therapy. Common procedures include uvulopalatopharyngoplasty (UPPP), tonsillectomy, septoplasty, and radiofrequency ablation of the soft palate. More advanced surgeries include hypoglossal nerve stimulation (Inspire therapy), which uses an implanted device to stimulate the tongue muscle during sleep, preventing airway collapse. Maxillomandibular advancement (MMA) is a more extensive skeletal surgery that repositions the jawbones and is highly effective in carefully selected patients. Bariatric surgery can lead to substantial weight loss and resolution of OSA in some cases. The NIH provides a detailed overview of all surgical and device-based options.

Lifestyle Modifications That Make a Difference

Lifestyle changes are foundational for managing sleep apnea, particularly for mild cases and as adjuncts to other therapies. Weight loss is the single most impactful change. A 10% reduction in body weight can reduce AHI by approximately 26 to 50%. Even modest weight loss improves pharyngeal collapsibility and metabolic outcomes. Structured weight-loss programs, dietary counseling, and regular aerobic exercise all contribute to sustained improvement.

Avoiding alcohol within three to four hours of bedtime is critical because alcohol relaxes pharyngeal muscles and depresses the central nervous system, worsening apnea. Similarly, sedative medications and muscle relaxants should be minimized. Smoking cessation reduces airway inflammation and edema. Sleeping on the side rather than the back reduces gravity-driven airway collapse; simple positional devices or a tennis ball sewn into the back of a sleep shirt can help maintain side-sleeping. Nasal congestion from allergies should be treated with saline rinses, antihistamines, or corticosteroid sprays to improve nasal airflow and CPAP tolerance.

Comparison of Sleep Apnea Treatment Options

Treatment	Best For	AHI Reduction	Adherence Rate	Key Considerations
CPAP / APAP	Moderate to severe OSA	70–95%	50–70% at 1 year	Mask discomfort, pressure intolerance, noise
BiPAP	CSA, CPAP intolerance, hypoventilation	60–85%	Similar to CPAP	Higher cost, dual-pressure settings
Oral Appliance (MAD)	Mild to moderate OSA	40–60%	70–80%	TMJ pain, dental shifts over time, custom fitting required
Positional Therapy	Positional OSA only (AHI doubled supine)	Variable (30–60% in selected patients)	60–70%	Not for non-positional or severe OSA; wearables work best
Hypoglossal Nerve Stimulation	Moderate to severe OSA (specific criteria)	60–75%	High (surgical implant)	Invasive, expensive, requires BMI < 35 and specific airway anatomy
Upper Airway Surgery (UPPP, tonsillectomy)	Anatomical obstruction, CPAP failure	40–60%	N/A (one-time)	Variable outcomes, pain, recovery time, not first-line
Weight Loss (bariatric or lifestyle)	Overweight/obese patients with OSA	25–50% per 10% weight loss	Varies	Sustained effort needed; bariatric surgery offers most durable results

Living with Sleep Apnea: Adherence and Long-Term Management

Successfully managing sleep apnea requires a long-term commitment. CPAP adherence is the cornerstone of effective therapy, yet it remains the biggest hurdle. Strategies to improve adherence include acclimatization during waking hours (wearing the mask for short periods), using the ramp feature to start at lower pressure, ensuring proper humidification to prevent nasal dryness, and addressing mask leaks promptly. Cognitive behavioral therapy for insomnia (CBT-I) may also help patients who struggle with both insomnia and sleep apnea (a combination known as COMISA).

Regular follow-up with a sleep medicine provider is essential. Objective adherence data can be downloaded from modern CPAP devices, allowing clinicians to monitor usage, residual AHI, and leak rates. Adjustments to pressure settings, mask type, or therapy mode can often resolve problems before they lead to abandonment of treatment. Support groups and online communities can also provide encouragement and practical tips.

For patients using oral appliances, annual dental follow-up is recommended to monitor for changes in bite or temporomandibular joint (TMJ) symptoms. Those who undergo surgery need periodic reassessment to ensure long-term success. Regardless of treatment modality, ongoing attention to weight management, sleep hygiene, and avoidance of alcohol or sedatives near bedtime maximizes outcomes.

Frequently Asked Questions About Sleep Apnea

Can sleep apnea go away on its own? Sleep apnea does not resolve spontaneously. However, significant weight loss can reduce or eliminate symptoms in some patients, particularly those with mild-to-moderate obesity-related OSA.

Is snoring always a sign of sleep apnea? Not all snorers have sleep apnea, but habitual loud snoring is a hallmark symptom. If snoring is accompanied by witnessed pauses in breathing, gasping, or daytime fatigue, a sleep evaluation is warranted.

How long does a sleep study take? An in-lab polysomnogram typically involves a single overnight stay of about 8 to 10 hours. Home sleep tests are performed over one to two nights in your own bed.

Can children have sleep apnea? Yes. Pediatric sleep apnea often results from enlarged tonsils or adenoids and can affect behavior, attention, and growth. Treatment may involve adenotonsillectomy or CPAP.

Does health insurance cover sleep apnea treatment? Most insurance plans, including Medicare and Medicaid, cover diagnostic sleep studies and CPAP therapy when medically necessary. Coverage for oral appliances and surgery varies by plan; prior authorization is often required.

What is the newest treatment for sleep apnea? Hypoglossal nerve stimulation (Inspire) gained FDA approval for moderate-to-severe OSA in patients who cannot tolerate CPAP. Newer advancements include closed-loop adaptive servo-ventilation (ASV) for CSA and pharmacologic therapies targeting weight loss, such as GLP-1 receptor agonists (e.g., tirzepatide), which are being investigated for their role in OSA management.

Can I travel with a CPAP machine? Yes. CPAP devices are classified as medical equipment and can be carried on airplanes without counting toward your carry-on limit. Most modern machines have universal power supplies for international travel.

This article is for informational purposes only and does not constitute professional medical advice. Always consult qualified healthcare professionals for guidance specific to your situation.